SWEDEN’S Public Health Agency has recommended that the protein-based Covid-19 vaccine Nuvaxovid should not be given to people 30 years of age and younger due to increased risk of myocarditis and pericarditis.
SWEDEN’S Public Health Agency has recommended that the protein-based Covid-19 vaccine Nuvaxovid should not be given to people 30 years of age and younger due to increased risk of myocarditis and pericarditis.